6 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Profectus Biosciences Competitors or Alternatives

Profectus Biosciences's top competitors include Novavax, Chimerix and GSK.

Unlock 26 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Profectus Biosciences's company profile

Jeffrey N. Meshulam

President

87/100
100 - 250
$25.2M
$5M - 25M
  • $25.2M
    $5M - 25M
  • 100 - 250
    $25.2M
  • $5M - 25M
  • 87/100
  • 100 - 250
  • $25.2M
  • $5M - 25M
View ProfileView
1
Profectus Biosciences's Competitor - Novavax logo

John C Jacobs

President & CEO

83/100
1,990
$2.4B
$682.2M
  • $2.4B
    $682.2M
  • 1,990
    $2.4B
  • $682.2M
  • 83/100
  • 1,990
  • $2.4B
  • $682.2M
View ProfileView
2
Profectus Biosciences's Competitor - Chimerix logo

Michael T. Andriole

President & CEO

82/100
90
$324.6M
$ < 1M
  • $324.6M
    $ < 1M
  • 90
    $324.6M
  • $ < 1M
  • 82/100
  • 90
  • $324.6M
  • $ < 1M
View ProfileView
3
Profectus Biosciences's Competitor - GSK logo

Dame Emma Walmsley

CEO

67/100
70,200
$2.3B
$41B
  • $2.3B
    $41B
  • 70,200
    $2.3B
  • $41B
  • 67/100
  • 70,200
  • $2.3B
  • $41B
View ProfileView
4
Profectus Biosciences's Competitor - Merck logo

Robert M. Davis

Chairman & CEO

78/100
69,000
$8B
$64.2B
  • $8B
    $64.2B
  • 69,000
    $8B
  • $64.2B
  • 78/100
  • 69,000
  • $8B
  • $64.2B
View ProfileView
5
Profectus Biosciences's Competitor - GlobeImmune logo

Jeffrey Dekker

President

69/100
22
$96.2M
$6.2M
  • $96.2M
    $6.2M
  • 22
    $96.2M
  • $6.2M
  • 69/100
  • 22
  • $96.2M
  • $6.2M
View ProfileView
Profectus Biosciences' top 29 competitors are Novavax, Chimerix, GSK, Altravax, Merck, GlobeImmune, OncoMed Pharmaceuticals, Moderna, Sanofi, Etubics, Viracta, CSL , NanoViricides, Atea, Roche, Visterra, Anavex, Ablynx N.V., Pfizer, Vaxart, CaroGen, Novartis, Immune Design, BioLegend, AbbVie, Tioma Therapeutics, Novus Biologicals, BioCryst and Juvaris BioTherapeutics. Together they have raised over 37.4B between their estimated 580.2K employees. Profectus Biosciences's revenue is the ranked 19th among it's top 10 competitors. The top 10 competitors average 14.5B. Profectus Biosciences has 210 employees and is ranked 14th among it's top 10 competitors. The top 10 competitors average 19,346.

Profectus Biosciences VS Novavax

Novavax is seen as one of Profectus Biosciences's biggest rivals. Novavax is headquartered in Gaithersburg, Maryland, and was founded in 1987. Like Profectus Biosciences, Novavax also works within the Pharmaceuticals & Biotechnology sector. Novavax generates 9,745% the revenue of Profectus Biosciences.

Profectus Biosciences VS Chimerix

Chimerix is seen as one of Profectus Biosciences's top competitors. Chimerix was founded in 2000, and its headquarters is in Durham, North Carolina. Chimerix operates in the Biotechnology industry. Chimerix has 120 fewer employees than Profectus Biosciences.

Profectus Biosciences VS GSK

GSK is one of Profectus Biosciences's top rivals. GSK is a Public company that was founded in London, England in 2000. GSK operates in the Pharmaceuticals industry. GSK has 69,990 more employees vs. Profectus Biosciences.

Looking for similar companies to Profectus Biosciences?

Similar Companies

Biotechnology companies in Baltimore

See 76 companies 
Biotechnology companies in Baltimore Metropolitan Area

See 126 companies 
Pharmaceuticals & Biotechnology companies in Baltimore

See 97 companies 
Pharmaceuticals & Biotechnology companies in Baltimore Metropolitan Area

See 174 companies 
Biotechnology companies in Maryland

See 395 companies 
Pharmaceuticals & Biotechnology companies in Maryland

See 526 companies 
Biotechnology companies with employees in 100-250 range

See 1,100 companies 
Companies in Baltimore with employees in 100-250 range

See 1,683 companies 
Pharmaceuticals & Biotechnology companies with employees in 100-250 range

See 1,792 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Profectus Biosciences and Profectus Biosciences's Competitors

April 1, 2025Benzinga
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") (NYSE:MRK) of a c...
March 31, 2025Fortune
Massive cuts to personnel and funding within the Department of Health and Human Services presents a headache for vaccine approval and development, anal...
April 1, 2025Benzinga
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") GSK of a class action securit...
Today 10:03 AMPharmabiz
Pfizer Inc. announced that the European Commission (EC) has issued a decision amending the marketing authorization for Abrysvo, the company's bivalent ...
March 31, 2025Pharmabiz
The US Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adu...
March 31, 2025Benzinga
States Change in Board Composition Sorely NeededExpresses Support for Radoff-JEC Group NomineesSTAMFORD, Texas, March 31, 2025 (GLOBE NEWSWIRE) -- Driv...
March 31, 2025Benzinga
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical c...
March 31, 2025Fortune
Massive cuts to personnel and funding within the Department of Health and Human Services presents a headache for vaccine approval and development, anal...
April 1, 2025Benzinga
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") MRK of a class ac...
April 1, 2025StreetInsider
New York, New York--(Newsfile Corp. - April 1, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositar...

Frequently Asked Questions about Profectus Biosciences

  1. Who are Profectus Biosciences's top competitors?

    Profectus Biosciences's top 3 competitors are Novavax, Chimerix, GSK.

  2. Who is similar to Profectus Biosciences?

    Novavax is the most similar to Profectus Biosciences. Chimerix and GSK are also similar to Profectus Biosciences.

  1. Are Profectus Biosciences and Novavax competitors?

    Yes, Novavax is one of Profectus Biosciences’s top competitors.